The Discovering CEO
In the current world of biopharma companies, the discovery function covers much more than hammering out new drug entities.
Stay updated with breaking news from Wayne Koberstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the current world of biopharma companies, the discovery function covers much more than hammering out new drug entities.
RebootRX believes that many off-patent pharmaceuticals have cancer-fighting potential, but their generic status makes them unattractive commercial...
Viking Therapeutics is a broad-target contender for treating NASH in a pipeline of new drugs for metabolic and endocrine disorders.
We sought out a biopharma enterprise where diversity always has been an operating principle, where it feeds the company’s intellectual life and...
Most biopharma industry observers would agree the leadership of a company by two co-equal CEOs is a rare thing. But when it does happen, the unusual...